International Clinical Trial: Efficacy and safety study of iparomlimab combined with Chemotherapy, with or without SBRT in the conversion Therapy of unresectable, locally advanced biliary tract cance: A multicenter, single-Arm, phase II prospective study

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121685) titled 'Efficacy and safety study of iparomlimab combined with Chemotherapy, with or without SBRT in the conversion Therapy of unresectable, locally advanced biliary tract cance: A multicenter, single-Arm, phase II prospective study' on April 1.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The affiliated hospital of southwest medical university

Condition: Intrahepatic Cholangiocarcinoma (ICC),Extrahepatic Cholangiocarcinoma (ECC),Gallbladder Carcinoma (GBC)

Recruitment Status: Recruiting

Phase: 2

Date of First Enrollment: 2026-04-01

Target Sample Size: experimental group:56...